moxifloxacin Indications/Contra | FAERs | Orange Book | BioActivity |

Stem definitionDrug idCAS RN
antibacterials, nalidixic acid derivatives 1854 151096-09-2

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • avelox
  • moxifloxacin
  • moxifloxacin hydrochloride
  • avolex
  • moxeza
  • moxifloxacine
  • moxifloxacin HCl
  • Molecular weight: 401.44
  • Formula: C21H24FN3O4
  • CLOGP: -0.08
  • LIPINSKI: 0
  • HAC: 7
  • HDO: 2
  • TPSA: 82.11
  • ALOGS: -3.38
  • ROTB: 4

Drug dosage:

DoseUnitRoute
0.40 g O
0.40 g P

Approvals:

DateAgencyCompanyOrphan
Dec. 10, 1999 FDA BAYER HLTHCARE

FDA Adverse Event Reporting System

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Anaphylactic reaction 2793.47 35.43 709 8540 12345 3364265
Hypersensitivity 1686.74 35.43 569 8680 27331 3349279
Rash 1616.25 35.43 709 8540 70112 3306498
Urticaria 1487.03 35.43 522 8727 28205 3348405
Pruritus 1195.28 35.43 509 8740 46324 3330286
Dyspnoea 1163.83 35.43 639 8610 102295 3274315
Dizziness 1095.88 35.43 557 8692 75955 3300655
Anaphylactic shock 807.79 35.43 225 9024 5514 3371096
Nausea 767.56 35.43 534 8715 129111 3247499
Tendonitis 749.76 35.43 187 9062 2932 3373678
Erythema 582.80 35.43 267 8982 28543 3348067
Electrocardiogram QT prolonged 573.96 35.43 201 9048 10594 3366016
Vomiting 534.89 35.43 372 8877 89159 3287451
Paraesthesia 515.54 35.43 242 9007 27306 3349304
Tendon rupture 501.28 35.43 133 9116 2685 3373925
Drug hypersensitivity 481.89 35.43 251 8998 35429 3341181
Swelling face 477.23 35.43 178 9071 11238 3365372
Palpitations 475.89 35.43 205 9044 18878 3357732
Toxic anterior segment syndrome 465.27 35.43 92 9157 441 3376169
Tendon pain 440.20 35.43 96 9153 797 3375813
Anxiety 424.16 35.43 239 9010 39390 3337220
Arthralgia 412.73 35.43 274 8975 60587 3316023
Diarrhoea 366.82 35.43 317 8932 104031 3272579
Neuropathy peripheral 362.03 35.43 163 9086 16644 3359966
Tremor 354.01 35.43 189 9060 27955 3348655
Lip swelling 346.12 35.43 120 9129 6111 3370499
Hypoaesthesia 340.66 35.43 177 9072 24762 3351848
Hypotension 333.04 35.43 222 9027 49292 3327318
Swollen tongue 331.35 35.43 119 9130 6724 3369886
Loss of consciousness 315.02 35.43 175 9074 27972 3348638
Pain in extremity 291.35 35.43 204 9045 49008 3327602
Rash generalised 286.60 35.43 118 9131 9664 3366946
Torsade de pointes 276.45 35.43 85 9164 2944 3373666
Oedema peripheral 272.46 35.43 171 9078 34190 3342420
Throat tightness 271.24 35.43 94 9155 4774 3371836
Hallucination 263.86 35.43 122 9127 13218 3363392
Pruritus generalised 261.45 35.43 96 9153 5773 3370837
Tachycardia 257.79 35.43 144 9105 23227 3353383
Myalgia 252.68 35.43 159 9090 31916 3344694
Burning sensation 249.29 35.43 104 9145 8800 3367810
Asthenia 243.19 35.43 206 9043 65459 3311151
Tendon disorder 234.63 35.43 60 9189 1038 3375572
Pharyngeal oedema 228.34 35.43 81 9168 4406 3372204
Confusional state 228.11 35.43 159 9090 37839 3338771
Pain 218.02 35.43 201 9048 71356 3305254
Swelling 214.45 35.43 119 9130 18925 3357685
Pyrexia 213.27 35.43 210 9039 80905 3295705
Clostridial infection 212.67 35.43 59 9190 1411 3375199
Blood pressure decreased 211.30 35.43 106 9143 13730 3362880
Syncope 209.15 35.43 130 9119 25503 3351107
Mental disorder 209.10 35.43 82 9167 5905 3370705
Hyperhidrosis 206.04 35.43 125 9124 23485 3353125
Chest discomfort 205.61 35.43 112 9137 17173 3359437
Heart rate increased 195.18 35.43 102 9147 14384 3362226
Clostridium difficile colitis 194.74 35.43 65 9184 2938 3373672
Musculoskeletal injury 193.78 35.43 32 9217 36 3376574
Corneal oedema 184.45 35.43 44 9205 562 3376048
Nervous system disorder 183.05 35.43 71 9178 4962 3371648
Angioedema 182.56 35.43 99 9150 15036 3361574
Stevens-Johnson syndrome 182.46 35.43 77 9172 6695 3369915
Flushing 180.54 35.43 96 9153 14017 3362593
Visual acuity reduced 176.77 35.43 82 9167 8932 3367678
Generalised erythema 173.50 35.43 55 9194 2106 3374504
Vision blurred 171.59 35.43 104 9145 19485 3357125
Eye pain 170.42 35.43 71 9178 5976 3370634
Abdominal pain 168.75 35.43 144 9105 46081 3330529
Muscular weakness 167.97 35.43 104 9145 20237 3356373
Nervousness 161.80 35.43 69 9180 6155 3370455
Insomnia 160.76 35.43 126 9123 35772 3340838
Ulcerative keratitis 157.48 35.43 41 9208 763 3375847
Ocular hyperaemia 157.08 35.43 64 9185 5089 3371521
Vessel puncture site reaction 154.44 35.43 25 9224 22 3376588
Endophthalmitis 152.97 35.43 46 9203 1473 3375137
Headache 152.45 35.43 187 9062 91793 3284817
Hypopyon 147.90 35.43 32 9217 254 3376356
Eye swelling 147.29 35.43 61 9188 5056 3371554
Skin injury 145.71 35.43 34 9215 392 3376218
Abdominal discomfort 144.46 35.43 92 9157 18792 3357818
Jaundice 144.22 35.43 74 9175 10033 3366577
Seizure 143.60 35.43 124 9125 40276 3336334
Feeling abnormal 141.65 35.43 105 9144 27420 3349190
Photophobia 138.26 35.43 50 9199 2872 3373738
Cardiac arrest 131.20 35.43 100 9149 27219 3349391
Disorientation 124.46 35.43 67 9182 10012 3366598
Rash erythematous 124.42 35.43 62 9187 7900 3368710
International normalised ratio increased 123.84 35.43 76 9173 14539 3362071
Chest pain 122.06 35.43 113 9136 40162 3336448
Uveitis 120.34 35.43 41 9208 1972 3374638
Ventricular tachycardia 120.12 35.43 55 9194 5807 3370803
Rash macular 119.56 35.43 50 9199 4244 3372366
Infusion site erythema 116.39 35.43 33 9216 855 3375755
Drug reaction with eosinophilia and systemic symptoms 116.09 35.43 59 9190 7836 3368774
Pneumonia 111.84 35.43 140 9109 70003 3306607
Corneal epithelium defect 111.65 35.43 24 9225 184 3376426
Arrhythmia 108.86 35.43 62 9187 10335 3366275
Visual impairment 108.35 35.43 69 9180 14077 3362533
Wheezing 105.61 35.43 56 9193 8115 3368495
Cardiovascular disorder 105.28 35.43 47 9202 4676 3371934
Hepatitis 105.10 35.43 59 9190 9566 3367044
Hypoglycaemia 102.65 35.43 67 9182 14251 3362359
Malaise 100.55 35.43 128 9121 65049 3311561
Iris transillumination defect 100.24 35.43 15 9234 2 3376608
Dry mouth 98.62 35.43 57 9192 9765 3366845
Injury 95.05 35.43 55 9194 9442 3367168
Emotional distress 94.87 35.43 48 9201 6312 3370298
Tinnitus 94.47 35.43 50 9199 7215 3369395
Speech disorder 94.37 35.43 54 9195 9078 3367532
Delirium 94.35 35.43 55 9194 9573 3367037
Feeling hot 93.69 35.43 51 9198 7785 3368825
Dysgeusia 93.18 35.43 58 9191 11366 3365244
Muscle spasms 92.31 35.43 81 9168 26822 3349788
Liver function test abnormal 91.57 35.43 60 9189 12841 3363769
Gait disturbance 89.54 35.43 81 9168 27911 3348699
Hepatic failure 89.21 35.43 55 9194 10597 3366013
Bronchitis 88.58 35.43 62 9187 14783 3361827
Chills 87.20 35.43 72 9177 21950 3354660
Corneal infiltrates 86.33 35.43 18 9231 117 3376493
Eye irritation 84.76 35.43 39 9210 4160 3372450
Renal failure 83.83 35.43 84 9165 32856 3343754
Anterior chamber cell 80.19 35.43 17 9232 121 3376489
Paraesthesia oral 80.07 35.43 32 9217 2416 3374194
Dysphagia 79.36 35.43 65 9184 19586 3357024
Hepatic enzyme increased 79.18 35.43 56 9193 13569 3363041
Joint swelling 78.67 35.43 61 9188 16996 3359614
Infusion site rash 77.68 35.43 17 9232 143 3376467
Punctate keratitis 75.57 35.43 18 9231 228 3376382
Panic attack 74.74 35.43 38 9211 5046 3371564
Abdominal pain upper 73.64 35.43 69 9180 24847 3351763
Adverse event 73.00 35.43 50 9199 11507 3365103
Off label use 72.34 35.43 99 9150 53878 3322732
Respiratory distress 71.98 35.43 44 9205 8344 3368266
Musculoskeletal pain 71.89 35.43 51 9198 12415 3364195
Anosmia 71.51 35.43 24 9225 1101 3375509
Aspartate aminotransferase increased 71.26 35.43 63 9186 21050 3355560
Sinusitis 70.95 35.43 57 9192 16711 3359899
Conjunctival hyperaemia 70.92 35.43 23 9226 947 3375663
Alanine aminotransferase increased 70.89 35.43 66 9183 23574 3353036
Intraocular pressure increased 70.10 35.43 29 9220 2393 3374217
Restlessness 68.95 35.43 41 9208 7397 3369213
Face oedema 68.30 35.43 36 9213 5148 3371462
Blister 67.84 35.43 43 9206 8691 3367919
Hypoaesthesia oral 67.76 35.43 29 9220 2604 3374006
Fatigue 67.33 35.43 140 9109 107100 3269510
Cold sweat 66.34 35.43 30 9219 3073 3373537
Vitritis 66.18 35.43 17 9232 299 3376311
Pulse absent 65.53 35.43 25 9224 1666 3374944
Multiple-drug resistance 64.99 35.43 17 9232 322 3376288
Toxic epidermal necrolysis 63.99 35.43 33 9216 4512 3372098
Cyanosis 63.92 35.43 34 9215 4952 3371658
Ageusia 63.00 35.43 28 9221 2754 3373856
Ventricular fibrillation 62.56 35.43 32 9217 4301 3372309
Aphasia 61.47 35.43 37 9212 6824 3369786
Heart rate irregular 61.28 35.43 29 9220 3295 3373315
Vertigo 61.16 35.43 45 9204 11587 3365023
Feeling jittery 60.64 35.43 26 9223 2345 3374265
Corneal opacity 59.70 35.43 16 9233 334 3376276
Obstructive airways disorder 58.99 35.43 23 9226 1626 3374984
Thrombocytopenia 58.65 35.43 72 9177 35196 3341414
Gait inability 58.32 35.43 37 9212 7488 3369122
Keratitis fungal 58.25 35.43 11 9238 39 3376571
Eye pruritus 57.66 35.43 26 9223 2645 3373965
Drug eruption 57.51 35.43 32 9217 5093 3371517
Acute kidney injury 57.51 35.43 85 9164 49598 3327012
Eyelid oedema 57.43 35.43 28 9221 3397 3373213
Tubulointerstitial nephritis 56.48 35.43 30 9219 4356 3372254
Serum sickness 56.33 35.43 19 9230 885 3375725
Hallucination, visual 55.91 35.43 30 9219 4446 3372164
Deafness 55.82 35.43 29 9220 4025 3372585
Adverse drug reaction 55.78 35.43 39 9210 9272 3367338
Anaphylactoid reaction 55.40 35.43 21 9228 1375 3375235
Acute hepatic failure 55.36 35.43 29 9220 4094 3372516
Mydriasis 55.33 35.43 26 9223 2908 3373702
Hepatotoxicity 55.24 35.43 32 9217 5499 3371111
Oedema mouth 55.15 35.43 20 9229 1156 3375454
Disturbance in attention 53.22 35.43 36 9213 8112 3368498
Cough 53.20 35.43 73 9176 39785 3336825
Infusion site reaction 52.99 35.43 15 9234 386 3376224
Muscle rupture 52.64 35.43 17 9232 690 3375920
Rash maculo-papular 50.90 35.43 31 9218 5836 3370774
Decreased appetite 49.46 35.43 72 9177 41418 3335192
Iridocyclitis 49.42 35.43 16 9233 655 3375955
Vasculitis 49.18 35.43 25 9224 3316 3373294
Bradycardia 48.91 35.43 46 9203 16623 3359987
Pseudomembranous colitis 48.51 35.43 17 9232 889 3375721
Glaucoma 48.43 35.43 23 9226 2633 3373977
Atrial fibrillation 48.32 35.43 54 9195 23887 3352723
Foreign body sensation in eyes 47.45 35.43 15 9234 568 3376042
Depression 47.39 35.43 69 9180 39701 3336909
Condition aggravated 46.64 35.43 68 9181 39165 3337445
Drug resistance 46.62 35.43 27 9222 4636 3371974
Incoherent 46.37 35.43 19 9230 1529 3375081
Hypokalaemia 46.17 35.43 41 9208 13764 3362846
Iris atrophy 46.03 35.43 9 9240 40 3376570
Weight decreased 45.49 35.43 68 9181 40043 3336567
Skin reaction 45.46 35.43 22 9227 2626 3373984
Circulatory collapse 45.03 35.43 29 9220 6020 3370590
Psychotic disorder 44.13 35.43 33 9216 8701 3367909
Corneal disorder 43.94 35.43 14 9235 544 3376066
Presyncope 43.75 35.43 27 9222 5204 3371406
Purpura senile 43.38 35.43 8 9241 24 3376586
Bronchospasm 43.29 35.43 25 9224 4269 3372341
Muscle twitching 42.82 35.43 24 9225 3873 3372737
Skin exfoliation 42.03 35.43 31 9218 8006 3368604
Hypoacusis 41.60 35.43 25 9224 4595 3372015
Agitation 40.71 35.43 45 9204 19661 3356949
Discomfort 40.60 35.43 28 9221 6508 3370102
Keratitis 40.53 35.43 14 9235 701 3375909
Physical disability 40.36 35.43 11 9238 245 3376365
Petechiae 40.16 35.43 21 9228 2953 3373657
Vessel puncture site pruritus 39.92 35.43 6 9243 1 3376609
Tarsal tunnel syndrome 39.35 35.43 8 9241 45 3376565
Iris hypopigmentation 39.33 35.43 7 9242 16 3376594
Infusion site pruritus 39.16 35.43 11 9238 275 3376335
Peripheral nerve injury 39.11 35.43 9 9240 97 3376513
Shock 39.10 35.43 28 9221 6909 3369701
Dermatitis exfoliative 38.85 35.43 20 9229 2723 3373887
Polyneuropathy 38.52 35.43 19 9230 2363 3374247
Throat irritation 38.46 35.43 25 9224 5269 3371341
Phlebitis 38.39 35.43 17 9232 1656 3374954
Hypersensitivity vasculitis 38.16 35.43 18 9231 2029 3374581
Body temperature increased 37.88 35.43 24 9225 4842 3371768
Eosinophilia 37.85 35.43 24 9225 4849 3371761
Neck pain 37.48 35.43 30 9219 8737 3367873
Chronic obstructive pulmonary disease 37.42 35.43 33 9216 10976 3365634
Dermatitis bullous 37.19 35.43 18 9231 2148 3374462
Ventricular extrasystoles 37.02 35.43 21 9228 3466 3373144
Ear discomfort 36.91 35.43 15 9234 1182 3375428
Hyperventilation 36.64 35.43 16 9233 1508 3375102
Clostridium test positive 36.32 35.43 12 9237 524 3376086
Rash pruritic 36.31 35.43 30 9219 9134 3367476
Vessel puncture site swelling 36.21 35.43 6 9243 7 3376603
Pallor 36.17 35.43 25 9224 5830 3370780
Eye inflammation 36.13 35.43 14 9235 973 3375637
Oxygen saturation decreased 35.81 35.43 31 9218 10060 3366550
Glossitis 35.77 35.43 13 9236 756 3375854
Anterior chamber disorder 35.68 35.43 8 9241 76 3376534
Coma 35.60 35.43 34 9215 12518 3364092
Corneal perforation 35.60 35.43 9 9240 148 3376462
Conjunctivitis 35.50 35.43 19 9230 2799 3373811
Eosinophilic pneumonia acute 35.48 35.43 9 9240 150 3376460

Pharmacologic Action:

SourceCodeDescription
ATC J01MA14 ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
QUINOLONE ANTIBACTERIALS
Fluoroquinolones
ATC S01AE07 SENSORY ORGANS
OPHTHALMOLOGICALS
ANTIINFECTIVES
Fluoroquinolones
MeSH PA D000900 Anti-Bacterial Agents
MeSH PA D000890 Anti-Infective Agents
MeSH PA D000970 Antineoplastic Agents
MeSH PA D004791 Enzyme Inhibitors
MeSH PA D059005 Topoisomerase II Inhibitors
MeSH PA D059003 Topoisomerase Inhibitors
CHEBI has role CHEBI:36047 antibacterial drug
FDA EPC N0000175937 Quinolone Antimicrobial
FDA Chemical/Ingredient N0000007606 Quinolones

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Septicemic plague indication 9012003 DOID:3481
Infection of skin AND/OR subcutaneous tissue indication 19824006
Staphylococcal pneumonia indication 22754005
Pneumonia due to Streptococcus indication 34020007
Pneumonic plague indication 38976008 DOID:10398
Pneumonia due to Mycoplasma pneumoniae indication 46970008
Peritonitis indication 48661000
Bacterial pneumonia indication 53084003 DOID:874
Pneumonia due to Klebsiella pneumoniae indication 64479007
Haemophilus influenzae pneumonia indication 70036007
Rhinoscleroma indication 72409005 DOID:11336
Abdominal abscess indication 75100008
Acute bacterial sinusitis indication 75498004
Infectious disease of abdomen indication 128070006
Bacterial conjunctivitis indication 128350005 DOID:9700
Infection due to Enterobacteriaceae indication 128945009
Bacterial infection due to Klebsiella pneumoniae indication 186435004
Pneumococcal pneumonia indication 233607000
Chlamydial pneumonia indication 233609002
Streptococcus pyogenes infection indication 302809008
Infection due to Staphylococcus aureus indication 406602003
Acute exacerbation of chronic bronchitis indication 425748003
Complicated Skin and Skin Structure E. Coli Infection indication
Complicated Skin and Skin Structure Infection indication
Haemophilus Influenzae Chronic Bronchitis indication
Complicated Skin and Skin Structure Staphylococcus Aureus Infection indication
Haemophilus Parainfluenzae Chronic Bronchitis indication
Streptococcus Pneumoniae Chronic Bronchitis indication
Moraxella Catarrhalis Pneumonia indication
Staphylococcus Chronic Bronchitis indication
Klebsiella Pneumoniae Chronic Bronchitis indication
Moraxella Catarrhalis Chronic Bronchitis indication
Acute tuberculosis off-label use 25629007
Pulmonary tuberculosis off-label use 154283005 DOID:2957
Cirrhosis of liver contraindication 19943007 DOID:5082
Torsades de pointes contraindication 31722008
Transplantation of heart contraindication 32413006
Tendinitis contraindication 34840004 DOID:971
Hypokalemia contraindication 43339004
Conduction disorder of the heart contraindication 44808001
Bradycardia contraindication 48867003
Transplant of kidney contraindication 70536003
Epilepsy contraindication 84757009 DOID:1826
Transplant of lung contraindication 88039007
Myasthenia gravis contraindication 91637004 DOID:437
Prolonged QT interval contraindication 111975006
Liver function tests abnormal contraindication 166603001
Drug-induced hepatitis contraindication 235876009
Peripheral nerve disease contraindication 302226006 DOID:574
Pseudomembranous enterocolitis contraindication 397683000 DOID:0060185
Myocardial ischemia contraindication 414795007 DOID:3393
Traumatic rupture of tendon contraindication 415749005
Congenital long QT syndrome contraindication 442917000
Severe Cerebral Arteriosclerosis contraindication

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 6.23 acidic
pKa2 8.54 Basic
pKa3 2.92 Basic

Orange Book patent data (new drug applications)

Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRoutePatent numberPatent expiration datePatent use
EQ 0.5% BASE VIGAMOX NOVARTIS PHARMS CORP N021598 April 15, 2003 RX SOLUTION/DROPS OPHTHALMIC 7671070 Sept. 29, 2019 METHOD OF COMBATING BACTERIA IN A PATIENT
EQ 0.5% BASE MOXEZA NOVARTIS PHARMS CORP N022428 Nov. 19, 2010 RX SOLUTION/DROPS OPHTHALMIC 7671070 Sept. 29, 2019 METHOD OF COMBATING BACTERIA IN A PATIENT
EQ 400MG BASE AVELOX BAYER HLTHCARE N021085 Dec. 10, 1999 RX TABLET ORAL 6610327 Oct. 29, 2019 METHOD OF COMBATING BACTERIA IN A PATIENT
400MG/250ML (1.6MG/ML) AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER BAYER HLTHCARE N021277 Nov. 30, 2001 DISCN SOLUTION IV (INFUSION) 6548079 July 25, 2020 METHOD OF COMBATING BACTERIA IN A PATIENT

Orange Book exclusivity data (new drug applications)

Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRouteExclusivity dateDescription
EQ 400MG BASE AVELOX BAYER HLTHCARE N021085 Dec. 10, 1999 RX TABLET ORAL Sept. 27, 2019 UPDATES TO THE LABELING TO INCLUDE RESULTS OF A TRIAL TO EVALUATE THE SAFETY OF MOXIFLOXACIN IN PEDIATRIC PATIENTS WITH COMPLICATED INTRA-ABDOMINAL INFECTIONS
400MG/250ML (1.6MG/ML) AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER BAYER HLTHCARE N021277 Nov. 30, 2001 DISCN SOLUTION IV (INFUSION) Sept. 27, 2019 UPDATES TO THE LABELING TO INCLUDE RESULTS OF A TRIAL TO EVALUATE THE SAFETY OF MOXIFLOXACIN IN PEDIATRIC PATIENTS WITH COMPLICATED INTRA-ABDOMINAL INFECTIONS

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
DNA gyrase Enzyme INHIBITOR IC50 6.52 CHEMBL CHEMBL
Topoisomerase IV Enzyme INHIBITOR CHEMBL CHEMBL
DNA topoisomerase 4 subunit A Enzyme IC50 6.10 CHEMBL
DNA gyrase subunit A Enzyme IC50 5.04 CHEMBL

External reference:

IDSource
DB00218 DRUGBANK_ID
C0875968 UMLSCUI
D00874 KEGG_DRUG
CHEMBL32 ChEMBL_ID
N0000005131 NDFRT
N0000148632 NDFRT
007927 NDDF
371296007 SNOMEDCT_US
d04500 MMSL
139462 RXNORM
4021185 VANDF
412439003 SNOMEDCT_US
152946 PUBCHEM_CID
CHEMBL1200735 ChEMBL_ID
C53598599T UNII
186826-86-8 SECONDARY_CAS_RN
C104727 MESH_SUPPLEMENTAL_RECORD_UI
7659 INN_ID
CHEBI:63611 CHEBI
MFX PDB_CHEM_ID

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
MOXEZA HUMAN PRESCRIPTION DRUG LABEL 1 0065-0006 SOLUTION 5 mg OPHTHALMIC NDA 14 sections
VIGAMOX HUMAN PRESCRIPTION DRUG LABEL 1 0065-4013 SOLUTION/ DROPS 5 mg OPHTHALMIC NDA 15 sections
Avelox HUMAN PRESCRIPTION DRUG LABEL 1 0085-1733 TABLET, FILM COATED 400 mg ORAL NDA 20 sections
Avelox HUMAN PRESCRIPTION DRUG LABEL 1 0085-1737 INJECTION, SOLUTION 400 mg INTRAVENOUS NDA 20 sections
Moxifloxacin Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 0093-7387 TABLET, FILM COATED 400 mg ORAL ANDA 20 sections
Moxifloxacin Ophthalmic Solution HUMAN PRESCRIPTION DRUG LABEL 1 0781-7135 SOLUTION/ DROPS 5 mg OPHTHALMIC NDA authorized generic 15 sections
Moxifloxacin HUMAN PRESCRIPTION DRUG LABEL 1 0904-6406 TABLET, FILM COATED 400 mg ORAL ANDA 20 sections
moxifloxacin hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 13668-201 TABLET 400 mg ORAL ANDA 20 sections
Avelox ABC Pack HUMAN PRESCRIPTION DRUG LABEL 1 16590-881 TABLET, FILM COATED 400 mg ORAL NDA 17 sections
Moxifloxacin HUMAN PRESCRIPTION DRUG LABEL 1 17478-519 SOLUTION/ DROPS 5 mg OPHTHALMIC ANDA 15 sections
VIGAMOX HUMAN PRESCRIPTION DRUG LABEL 1 21695-968 SOLUTION 5 mg OPHTHALMIC NDA 13 sections
Moxifloxacin Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 40032-034 TABLET 400 mg ORAL ANDA 20 sections
Moxifloxacin Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 43063-580 TABLET, FILM COATED 400 mg ORAL NDA authorized generic 20 sections
Moxifloxacin Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 43063-585 TABLET, FILM COATED 400 mg ORAL NDA authorized generic 20 sections
Moxifloxacin Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 47781-268 TABLET, FILM COATED 400 mg ORAL NDA authorized generic 20 sections
Avelox HUMAN PRESCRIPTION DRUG LABEL 1 49999-455 TABLET, FILM COATED 400 mg ORAL NDA 21 sections
VIGAMOX HUMAN PRESCRIPTION DRUG LABEL 1 50090-0859 SOLUTION/ DROPS 5 mg OPHTHALMIC NDA 15 sections
Moxifloxacin Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 50268-576 TABLET, FILM COATED 400 mg ORAL ANDA 21 sections
Avelox HUMAN PRESCRIPTION DRUG LABEL 1 50419-530 TABLET, FILM COATED 400 mg ORAL NDA 20 sections
Avelox HUMAN PRESCRIPTION DRUG LABEL 1 50419-537 INJECTION, SOLUTION 400 mg INTRAVENOUS NDA 20 sections
Moxifloxacin Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 51991-943 TABLET 400 mg ORAL ANDA 20 sections
Avelox HUMAN PRESCRIPTION DRUG LABEL 1 54868-4367 TABLET, FILM COATED 400 mg ORAL NDA 21 sections
VIGAMOX HUMAN PRESCRIPTION DRUG LABEL 1 54868-4798 SOLUTION 5 mg OPHTHALMIC NDA 15 sections
Moxifloxacin HUMAN PRESCRIPTION DRUG LABEL 1 55111-112 TABLET, FILM COATED 400 mg ORAL ANDA 20 sections
Avelox HUMAN PRESCRIPTION DRUG LABEL 1 55289-077 TABLET, FILM COATED 400 mg ORAL NDA 20 sections
Moxifloxacin Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 57237-156 TABLET, FILM COATED 400 mg ORAL ANDA 20 sections
Moxifloxacin Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 60429-893 TABLET 400 mg ORAL ANDA 20 sections
VIGAMOX HUMAN PRESCRIPTION DRUG LABEL 1 61786-058 SOLUTION/ DROPS 5 mg OPHTHALMIC NDA 15 sections
Moxifloxacin HUMAN PRESCRIPTION DRUG LABEL 1 63323-850 INJECTION, SOLUTION 400 mg INTRAVENOUS NDA 20 sections
Moxifloxacin Hydrochloride HUMAN PRESCRIPTION DRUG LABEL 1 65862-603 TABLET, FILM COATED 400 mg ORAL ANDA 20 sections